Bioinks to 3D print microenvironments that mimic the physical and biochemical properties of lung tissue
Webinar
The lung’s cellular environment is incredibly complex, with physical and biochemical signals constantly shaping cell behavior. Reproducing these interactions in vitro remains a major challenge, especially when existing bioinks lack the printability and flexibility needed to accurately model healthy and diseased tissue.
Discover a next-generation 3D bioprinting bioink platform designed to overcome key limitations of conventional bioinks. Learn how tunable physical and biochemical properties, high print fidelity, and strong cell viability can be combined to create more physiologically relevant lung tissue models, including applications in lung fibrosis research.
Key takeaways
- Understand how physical and biochemical microenvironmental cues influence lung cell behavior and tissue function.
- Learn strategies to improve bioink printability, tunability, and long-term cell viability.
- Explore approaches for engineering physiologically relevant 3D lung tissue microenvironments.
- Discover applications of advanced bioinks in lung fibrosis and other pulmonary disease models.
- Gain insights into developing more predictive in vitro platforms for drug discovery and translational research.
Who should attend
Researchers, tissue engineers, cell biologists, and translational scientists interested in advanced in vitro models, regenerative medicine, and pulmonary disease research.
Speakers

Dr. Jose Moran-Mirabal
McMaster University, Department of Chemistry and Chemical Biology
Professor and University Scholar
Dr. Jose Moran-Mirabal is Professor of Chemistry and Chemical Biology at McMaster University and Founding Scientific Director of its Centre for Advanced Light Microscopy. He leads research in 3D bioprinting, micro/nano-fabrication, interfacial biomaterials, and high-resolution microscopy. He is CEO/Co-Founder of Tessella Biosciences and president of the Microscopy Society of Canada.

Shishir Agrahari
Merck
Senior Global Product Manager - Biomedical Materials
Shishir Agrahari leads Merck's Biomedical Materials portfolio. He drives next-generation biomaterials and polymer innovations for research and industry, collaborating with customers to address their challenges. With 12+ years in life sciences, his background includes cancer immunology and drug delivery, portfolio strategy, and successful product launches.
Materials science and engineering
- 3D bioprinting
Duration:1h
Language:English
Session 1:presented October 14, 2026